NEWS

GlaxoSmithKline extends InforSense deal

GlaxoSmithKline (GSK) has signed an agreement to continue its use of the Inforsense business and scientific intelligence tools by 800 employees across the organisation.'GSK is one of our key customers and we are looking forward to continued work with the company,' said Jonathan Sheldon, chief scientific officer, InforSense. 'By renewing its commitment to InforSense, GSK will continue to benefit from the productivity gains delivered by the InforSense platform in quickly developing scientific applications.'

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers